Composition:
Each tablet contains: Apixaban…………………………………. 5mg.
Indications:
Anticoagulant used for the prophylaxis of stroke and systemic embolism and the prevention of venous thromboembolic events (VTE) in adult patients undergoing elective hip or knee replacement.
Dosage:
• The recommended dose for most patients is one 5mg tablet taken orally twice daily, taken with water, on a full or empty stomach.
• For patients undergoing hip replacement: the recommended course of treatment is from 32 to 38 days;
• For patients undergoing knee replacement: the recommended course of treatment is from 10 to 14 days.
• First dose should be taken 12-24 hours before surgery.
Precautions:
• If severe bleeding occurs, apixaban should be discontinued immediately.
• Apixaban is not recommended during pregnancy.
Contraindications:
• Patients who are allergic to the active ingredient or any excipients in the tablets.
• Patients with liver disease with coagulopathy and clinically associated bleeding risk.
• Patients with severe hepatic impairment.
Adverse Effects：
• Common adverse reactions include anemia, bleeding, bruising and nausea. Apixaban may cause an increased risk of internal bleeding in some tissues or organs, which may lead to anemia.
Dosage form: Yellow film-coated tablet.
Expiry date: 3 years after date of manufacture.
Packaging: 28 tablets per bottle.
Storage:
• Store below 30℃ in original packaging.
• Keep out of reach of children.
DISCLAIMER
The information on this website about our medications is intended for general educational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay seeking care because of something you have read on this website.
For your safety:
Do not self-diagnose or treat any medical condition based solely on the information on this website. If you have any questions or concerns about a medication, please talk to your doctor or pharmacist.
